DELIVER A PRESENTATION AT TIDES DIGITAL WEEK
Sponsor this 4-day webcast series, September 16-19, 2019 to engage prospects, reinforce your thought leadership status, and raise your profile — all while generating leads.
2019 Keynote Speakers
Stay tuned for the 2020 speakers to be announced!
TIDES Offers the Science, Technologies and Partners You Need to Grow Your Business
1200+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
150+ CASE STUDIES AND NEW DATA PRESENTATIONS
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.
Conventional peptide synthesis technologies are facing several challenges such as long manufacturing lead time and low production yield.
In this exclusive whitepaper, you can read all about JITSUBO's Molecular Hiving™ technology and how it provides high-quality and low-cost peptide APIs with short lead time by using innovative TAG-assisted liquid phase peptide synthesis (LPPS) to manufacture the peptides.
TIDES Tube - Watch Past Keynote Presentations
TIDES Tube provides the global oligonucleotide and peptide community with exclusive video content designed to help accelerate promising therapeutics from early discovery to late-stage development & commercialization.
Check out TIDES Tube now to watch video of last year's keynote presentations.
Do you want to highlight your company's expertise in TIDES Tube? Contact us today!
cross-fertilize ideas and best practices with researchers from different disciplines
TIDES offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical and CMC to late-stage development and commercialization.
- Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
- Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
- Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
- Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
CONNECT WITH KEY BUYERS AT TIDES 2020 in Boston
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
(Companies A-I) Contact Michael Dunnet: MDunnet@knect365lifesciences.com | +1 (857) 504-6732
(Companies J-Z) Contact Michael Moriarty: MMoriarty@knect365lifesciences.com | +1-646-895-7412